[HTML][HTML] A Jordanian Multidisciplinary Consensus Statement on the Management of Dyslipidemia
E Al Mousa, S Al-Azzam, M Araydah… - Journal of Clinical …, 2023 - mdpi.com
Atherosclerotic cardiovascular disease (ASCVD) is the primary contributor to global mortality
rates, which significantly escalates healthcare expenditures. Risk factors for ASCVD …
rates, which significantly escalates healthcare expenditures. Risk factors for ASCVD …
[HTML][HTML] Aggravating effect of abnormal low-density protein cholesterol level on coronary atherosclerotic plaque in type 2 diabetes mellitus patients assessed by …
YN Jiang, Y Gao, YS Zhang, CY Min, LT Shen… - Cardiovascular …, 2024 - Springer
Background The abnormal low-density protein cholesterol (LDL-C) level in the development
of atherosclerosis is often comorbid in individuals with type 2 diabetes mellitus (T2DM). This …
of atherosclerosis is often comorbid in individuals with type 2 diabetes mellitus (T2DM). This …
[HTML][HTML] Prevalence and patterns of dyslipidemia among lipid-lowering drug-naïve patients with type 2 diabetes mellitus–A countrywide study in Bangladesh
ABM Kamrul-Hasan, MS Alam, N Zarin… - … and Metabolic Science, 2023 - Elsevier
Background Dyslipidemia is a major risk factor for cardiovascular disease in patients with
type 2 diabetes mellitus (T2DM). This countrywide study explored the prevalence and …
type 2 diabetes mellitus (T2DM). This countrywide study explored the prevalence and …
[HTML][HTML] Utilization of hypolipidemic drugs, patterns, and factors affecting dyslipidemia among type 2 diabetes mellitus at a tertiary care teaching hospital in South India
S Khot, A Chakraborty, S Vijaykumar - Cureus, 2023 - ncbi.nlm.nih.gov
Background The prevalence of dyslipidemia is higher in type 2 diabetes mellitus (T2DM)
and hypolipidemic drugs like statins are effective for the primary and secondary prevention …
and hypolipidemic drugs like statins are effective for the primary and secondary prevention …
Effects of resveratrol on lipid profile of diabetes mellitus wound healing of male Wistar rats
There is a growing body of research showing the potential health benefits of resveratrol,
including anti-inflammatory and antioxidant properties. This study investigates the potential …
including anti-inflammatory and antioxidant properties. This study investigates the potential …
[PDF][PDF] Association of Blood Glucose and Lipid Profile Concentrations in Diabetic Patients Attending Gisenyi District Hospital in Rwanda: A Cross-Sectional Study
E Ndagijimana, A Nshimiyimana, T Habyarimana… - East Africa Science, 2024 - ajol.info
Association of Blood Glucose and Lipid Profile Concentrations in Diabetic Patients Attending
Gisenyi District Hospital in Rwanda Page 1 ORIGINAL ARTICLE Association of Blood Glucose …
Gisenyi District Hospital in Rwanda Page 1 ORIGINAL ARTICLE Association of Blood Glucose …
[PDF][PDF] Endocrine and Metabolic Science
ABM Kamrul-Hasan, MS Alam, N Zarin, MA Kabir… - researchgate.net
Background: Dyslipidemia is a major risk factor for cardiovascular disease in patients with
type 2 diabetes mellitus (T2DM). This countrywide study explored the prevalence and …
type 2 diabetes mellitus (T2DM). This countrywide study explored the prevalence and …
[PDF][PDF] TYPE 2 DIABETES MULLITUS PATIENTS WITH AND WITHOUT HYPERTENSION: XANTHINE OXIDASE ACTIVITY AND URIC ACID CONCENTRATION
BS Tarif, ZH AL-Hellawi - chem.uaic.ro
A metabolic condition known as type 2 diabetes mellitus (T2DM) has spread all over the
world. Pancreatic insulin resistance and β-cell dysfunction are its defining features. In 2021 …
world. Pancreatic insulin resistance and β-cell dysfunction are its defining features. In 2021 …
Exploring the Link between Tgf-Β Gene Variants With Type 2 Diabetes And Nephropathy: Findings from a South Indian Study
C Swetha, U Najiya Mahwish, S Bhushan Raju… - Sri and Sumanlatha … - papers.ssrn.com
Limited number of studies from South India investigated the association of Transforming
Growth factor-beta1 (TGF-β1) gene markers with Type 2 Diabetes Mellitus (T2DM) and Type …
Growth factor-beta1 (TGF-β1) gene markers with Type 2 Diabetes Mellitus (T2DM) and Type …
[PDF][PDF] Endocrine and Metabolic Science
VJ Vera-Ponce, GZ Zeñas-Trujillo, JA Loayza-Castro… - researchgate.net
Background: Dyslipidemia is a major risk factor for cardiovascular disease in patients with
type 2 diabetes mellitus (T2DM). This countrywide study explored the prevalence and …
type 2 diabetes mellitus (T2DM). This countrywide study explored the prevalence and …